Search research articles
Contact Us
Filters
Showing results (141-150 of 235) with videos related to
Page
of 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma
Mark A Dickson, William D Tap, Mary Louise Keohan, et al.
Sarcoma
|
June 16, 2015
Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma
Mark A Dickson, David R D'Adamo, Mary L Keohan, et al.
Clinical Orthopaedics and Related Research
|
August 24, 2022
Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN
John H Healey, William D Tap, Heather L Gelhorn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 29, 2023
Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response
Israel S Kasago, Walid K Chatila, Cecilia M Lezcano, et al.
The Oncologist
|
December 8, 2020
Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors
James H Lewis, Hans Gelderblom, Michiel van de Sande, et al.
JACC. Cardiovascular Imaging
|
July 6, 2023
Incremental Utility of First-Pass Perfusion CMR for Prognostic Risk Stratification of Cancer-Associated Cardiac Masses
Angel T Chan, Tania Ruiz Maya, Christine Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2020
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
William D Tap, Victor M Villalobos, Gregory M Cote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome
Evan Rosenbaum, Kenneth Seier, Chaitanya Bandlamudi, et al.
Acta Orthopaedica
|
May 12, 2021
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial
Michiel Van De Sande, William D Tap, Heather L Gelhorn, et al.
Journal for Immunotherapy of Cancer
|
September 29, 2024
A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses
Nathan D Seligson, James L Chen, Austin C Goodrich, et al.
Page
of 24
Search research articles
Search
Showing results (141-150 of 235) with videos related to
Sort By:
Page
of 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma
Mark A Dickson, William D Tap, Mary Louise Keohan, et al.
Sarcoma
|
June 16, 2015
Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma
Mark A Dickson, David R D'Adamo, Mary L Keohan, et al.
Clinical Orthopaedics and Related Research
|
August 24, 2022
Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN
John H Healey, William D Tap, Heather L Gelhorn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 29, 2023
Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response
Israel S Kasago, Walid K Chatila, Cecilia M Lezcano, et al.
The Oncologist
|
December 8, 2020
Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors
James H Lewis, Hans Gelderblom, Michiel van de Sande, et al.
JACC. Cardiovascular Imaging
|
July 6, 2023
Incremental Utility of First-Pass Perfusion CMR for Prognostic Risk Stratification of Cancer-Associated Cardiac Masses
Angel T Chan, Tania Ruiz Maya, Christine Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2020
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
William D Tap, Victor M Villalobos, Gregory M Cote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome
Evan Rosenbaum, Kenneth Seier, Chaitanya Bandlamudi, et al.
Acta Orthopaedica
|
May 12, 2021
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial
Michiel Van De Sande, William D Tap, Heather L Gelhorn, et al.
Journal for Immunotherapy of Cancer
|
September 29, 2024
A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses
Nathan D Seligson, James L Chen, Austin C Goodrich, et al.
Page
of 24